- Revenue (TTM): $24.31 billion
- Founded: 1920s
- Headquarters: Denmark
Novo Nordisk, founded in 1923 and headquartered in Bagsværd, Denmark, is a global leader in diabetes care and hormone replacement therapies. The company is best known for its pioneering work in insulin production, and it remains a dominant force in the global diabetes market with its products like NovoRapid and Tresiba. Novo Nordisk also specializes in therapies for obesity, growth hormone deficiencies, and hemophilia. With a focus on innovation and patient-centric care, Novo Nordisk continues to develop groundbreaking treatments to improve the lives of patients suffering from chronic conditions like diabetes, making it a key player in global healthcare with a commitment to sustainable solutions and access to medicine.
- Revenue (TTM): $24.69 billion (2020)
- Founded: 1987
- Headquarters: California, US
Gilead Sciences, founded in 1987 and headquartered in Foster City, California, is a global biotechnology company specializing in antiviral drugs used to treat HIV, hepatitis, and other infectious diseases. The company is renowned for its breakthrough treatments, such as Truvada and Harvoni, which have revolutionized the management of HIV and hepatitis C. Gilead’s commitment to improving global public health has expanded its portfolio to include cancer therapies, as well as pioneering treatments for inflammatory diseases. With a strong emphasis on research and development, Gilead continues to lead the fight against infectious diseases while exploring new frontiers in immuno-oncology and gene therapies.
- Revenue (TTM): $26.32 billion (2022)
- Founded: 1980
- Headquarters: Thousand Oaks, California, US
Amgen, founded in 1980 and headquartered in Thousand Oaks, California, is one of the world’s largest biotechnology companies. Known for its groundbreaking contributions to oncology and immunology, Amgen has developed several life-changing therapies, including the cancer drug Neulasta and the rheumatoid arthritis treatment Enbrel. The company’s research focuses on molecular biology and genetic engineering to create innovative therapies that address serious illnesses like cancer, cardiovascular disease, and neurological disorders. Amgen’s commitment to improving human health through biotechnology has solidified its position as a leader in both the scientific and healthcare industries, driving advancements in patient care and life-saving treatments.
- Revenue (TTM): $39.21 billion (2021)
- Founded: 2006
- Headquarters: Waltham, Massachusetts, US
Thermo Fisher Scientific, founded in 1956 and headquartered in Waltham, Massachusetts, is a global leader in laboratory supplies, reagents, and services. The company provides essential tools and technologies that enable scientific innovation across a wide range of industries, including life sciences, healthcare, and environmental research. Thermo Fisher’s portfolio includes high-quality instruments, laboratory equipment, and consumables, as well as advanced services in drug discovery, diagnostics, and clinical trials. By enabling researchers to accelerate the discovery and development of new treatments, Thermo Fisher has become an indispensable partner in the global life sciences ecosystem, helping to advance scientific knowledge and improve public health.
- Revenue (TTM): $8.7 billion
- Founded: 1989
- Headquarters: Boston, Massachusetts, US
Vertex Pharmaceuticals, founded in 1989 and headquartered in Boston, Massachusetts, is a biotechnology company best known for its pioneering work in cystic fibrosis (CF) treatment. The company’s breakthrough drug, Kalydeco, was the first to treat the root cause of CF by targeting the defective protein responsible for the disease. Vertex has continued to innovate with its highly effective combination therapies, such as Orkambi and Trikafta, which have significantly improved the lives of CF patients. With a strong focus on genetic medicines, Vertex is also expanding its research efforts into gene-editing therapies, particularly for other serious genetic diseases, positioning the company as a leader in developing transformative treatments that target the genetic basis of diseases.
- Revenue (TTM): $13.71 billion
- Founded: 1998
- Headquarters: Westchester County, New York
Regeneron Pharmaceuticals, founded in 1988 and headquartered in Tarrytown, New York, is a leader in biotechnology with a focus on developing innovative therapies for serious medical conditions. The company’s research spans oncology, immunology, ophthalmology, and rare diseases. Notably, Regeneron’s breakthrough drug, Dupixent, has transformed the treatment of allergic diseases like asthma and eczema. The company is also known for its contributions to cancer treatment, including its PD-1 inhibitor, Libtayo. Regeneron’s strong emphasis on genetic research and the development of monoclonal antibody therapies has positioned it as a key player in delivering novel treatments that improve patient outcomes worldwide.
- Revenue (TTM): $3.239 billion (2020)
- Founded: 1998
- Headquarters: San Diego, California
Illumina, founded in 1998 and headquartered in San Diego, California, is a global leader in genomics, providing innovative sequencing and array-based technologies. The company’s products and services enable scientists to conduct advanced genetic research, ranging from basic research to personalized medicine. Illumina’s next-generation sequencing technologies have revolutionized the field of genomics by making genetic analysis faster, more affordable, and more accessible. With applications in diagnostics, drug development, and disease prevention, Illumina continues to drive progress in precision medicine, accelerating the pace of discoveries in genetics and genomics.
- Revenue (TTM): $20.37 billion
- Founded: 2008
- Headquarters: Mainz, Germany
BioNTech, founded in 2008 and headquartered in Mainz, Germany, is a biotech company at the forefront of mRNA technology. BioNTech gained international recognition for developing one of the first COVID-19 vaccines in partnership with Pfizer, a groundbreaking achievement in the field of vaccine development. The company specializes in the use of mRNA technology to treat cancer and infectious diseases. BioNTech is advancing its pipeline with novel cancer immunotherapies and other treatments that harness the power of the immune system, positioning it as a leader in the next generation of biotechnology and precision medicine.
- Revenue (TTM): $20.68 billion
- Founded: 2010
- Headquarters: Cambridge, Massachusetts
Moderna, founded in 2010 and headquartered in Cambridge, Massachusetts, is a biotechnology company that has revolutionized the use of messenger RNA (mRNA) technology for vaccine and therapeutic development. The company gained global prominence for developing one of the first COVID-19 vaccines using its innovative mRNA platform. Beyond vaccines, Moderna is developing mRNA-based treatments for infectious diseases, cancer, and rare genetic disorders. With its focus on cutting-edge technology and the ability to rapidly respond to public health challenges, Moderna is a leading force in transforming the future of medicine and vaccine development.
- Revenue (TTM): $10.61 billion (2021)
- Founded: 1916
- Headquarters: Melbourne, Australia
CSL Limited, founded in 1916 and headquartered in Melbourne, Australia, is a global biotechnology company specializing in biotherapies. CSL operates in two major segments: CSL Behring, which focuses on immunology, hematology, and respiratory diseases, and CSL Plasma, a network of blood collection centers. The company is best known for its therapies in rare and serious diseases, including hemophilia and immune deficiencies. With a strong commitment to research and development, CSL has become a leader in plasma-derived therapies and continues to innovate in the areas of immunotherapy and vaccine development.
- Revenue (TTM): $43.7 billion (2022)
- Founded: 1888
- Headquarters: Chicago, US
Abbott Laboratories, founded in 1888 and headquartered in Abbott Park, Illinois, is a global healthcare company with a broad portfolio spanning diagnostics, medical devices, nutrition, and pharmaceuticals. Abbott is recognized for its contributions to health monitoring and diagnostics, including groundbreaking innovations like the FreeStyle Libre continuous glucose monitoring system for diabetes. The company also develops cutting-edge medical devices, vaccines, and treatments in cardiovascular care, neuroscience, and infectious diseases. Abbott’s commitment to improving patient care and enhancing global health access has made it a trusted leader in the healthcare industry.
- Revenue (TTM): $3.33 billion
- Founded: 2002
- Headquarters: Delaware, US
Incyte Corporation, founded in 2002 and headquartered in Wilmington, Delaware, is a biotechnology company focused on developing therapies for oncology, immunology, and inflammation. The company’s drug, Jakafi, is a leading treatment for myelofibrosis, a rare blood cancer. Incyte is also focused on immuno-oncology, with a strong pipeline of drugs aimed at targeting the immune system to fight cancer. In addition to its work in oncology, Incyte is advancing therapies for autoimmune diseases, positioning itself as a key player in precision medicine and innovative cancer treatments.
- Daiichi Sankyo: A Global Innovator in Oncology
- Revenue (TTM): $9.4 billion
- Founded: 1899
- Headquarters: Tokyo, Japan
Daiichi Sankyo, founded in 1899 and headquartered in Tokyo, Japan, is a global pharmaceutical company known for its commitment to advancing oncology and cardiovascular care. The company has made significant contributions to cancer treatment with its targeted therapies, including the groundbreaking drug Enhertu, which is used for breast cancer and other solid tumors. Daiichi Sankyo is also focused on cardiovascular diseases, developing innovative treatments for hypertension, heart failure, and lipid disorders. With a strong emphasis on research and development, Daiichi Sankyo continues to innovate in oncology and other therapeutic areas to improve patient outcomes worldwide.
- Takeda Pharmaceutical: Advancing Global Healthcare
- Revenue (TTM): $10.61 billion (2021)
- Founded: 1781
- Headquarters: Tokyo, Japan
Takeda Pharmaceutical, founded in 1781 and headquartered in Tokyo, Japan, is one of the largest pharmaceutical companies in the world, with a diverse portfolio spanning oncology, gastroenterology, neuroscience, and rare diseases. Takeda’s oncology division is known for its development of innovative treatments like Velcade and Ninlaro for multiple myeloma. The company is also a leader in gastroenterology, particularly with its therapies for Crohn’s disease and ulcerative colitis. With a focus on global health, Takeda strives to improve lives through its research and commitment to delivering effective treatments for complex diseases.
- Revenue (TTM): $14.38 billion (2019)
- Founded: 1978
- Headquarters: Massachusetts, US
Biogen, founded in 1978 and headquartered in Cambridge, Massachusetts, is a leading biotechnology company specializing in the development of treatments for neurological and neurodegenerative diseases. Biogen’s groundbreaking therapies for multiple sclerosis, including Avonex and Tecfidera, have transformed the treatment landscape for the disease. The company is also advancing therapies for Alzheimer’s disease, spinal muscular atrophy (SMA), and other neurological disorders. With a strong focus on neurology and a commitment to improving the lives of patients with chronic conditions, Biogen continues to lead in the field of neuroscience and neurodegenerative disease research.
- Chugai Pharmaceutical: Advancing Cancer and Rare Disease Therapies
- Revenue (TTM): $9.26 billion
- Founded: 1925
- Headquarters: Tokyo, Japan
Chugai Pharmaceutical, founded in 1925 and headquartered in Tokyo, Japan, is a leading biopharmaceutical company known for its research and development in oncology and rare diseases. A key player in the Japanese pharmaceutical market, Chugai is recognized for its innovative cancer treatments, including the monoclonal antibody Rituxan (in collaboration with Genentech) and Perjeta. The company’s focus on immuno-oncology and personalized medicine has positioned it as a leader in developing therapies for rare diseases and cancers, contributing significantly to the global fight against cancer and improving patient care.
- Charles River Laboratories: Enabling Drug Discovery and Development
- Revenue (TTM): $3.98 billion (2022)
- Founded: 1947
- Headquarters: Wilmington, Massachusetts, US
Charles River Laboratories, founded in 1947 and headquartered in Wilmington, Massachusetts, is a global leader in providing comprehensive services to the pharmaceutical and biotechnology industries. The company specializes in early-stage contract research, offering services ranging from drug discovery and preclinical development to manufacturing and regulatory support. Charles River Laboratories plays a critical role in helping clients accelerate the development of new therapeutics, providing essential research tools, animal models, and testing services. The company’s contributions to the drug development process support the global healthcare ecosystem and help bring new medicines to market more efficiently.
- Lonza: A Global Leader in Biopharmaceutical Manufacturing
- Revenue (TTM): 4.508 billion CHF (2021)
- Founded: 1897
- Headquarters: Basel, Switzerland
Lonza, founded in 1897 and headquartered in Basel, Switzerland, is a global leader in the life sciences and biopharmaceutical manufacturing sectors. The company provides essential services for the development and production of biologic drugs, cell and gene therapies, and other advanced therapies. Lonza’s expertise spans from contract development and manufacturing to cell culture and microbial production. The company’s work supports pharmaceutical and biotech companies in the creation of life-saving treatments, particularly in the fields of oncology, immunology, and regenerative medicine, making it a key player in advancing the biopharmaceutical industry.
- Jazz Pharmaceuticals: Advancing Treatments for Neurological and Rare Diseases
- Revenue (TTM): $3.58 billion
- Founded: 2005
- Headquarters: Dublin, Ireland
Jazz Pharmaceuticals, founded in 2003 and headquartered in Dublin, Ireland, is a global biopharmaceutical company specializing in rare diseases and central nervous system (CNS) disorders. The company’s portfolio includes therapies for conditions like narcolepsy, epilepsy, and various forms of cancer. Jazz is best known for its product Xyrem, which is used to treat narcolepsy, and for its focus on developing treatments that address unmet needs in the rare disease space. Through its research and acquisitions, Jazz Pharmaceuticals is committed to improving the lives of patients with neurological conditions and rare diseases.
- Novavax: Pioneering Vaccine Development
- Revenue (TTM): $2.39 billion
- Founded: 1987
- Headquarters: Gaithersburg, Maryland, US
Novavax, founded in 1987 and headquartered in Gaithersburg, Maryland, is a biotechnology company focused on developing vaccines for infectious diseases. The company’s most notable achievement came with the development of its COVID-19 vaccine, NVX-CoV2373, which was one of the key players in the global fight against the pandemic. Novavax’s approach uses protein-based vaccine technology, providing an alternative to mRNA-based vaccines. The company is also developing vaccines for other infectious diseases, such as influenza and respiratory syncytial virus (RSV), and continues to be a major force in advancing the science of vaccine development.
Vir Biotechnology: Tackling Infectious Diseases with Innovative Solutions
- Revenue (TTM): $2.37 billion
- Founded: 2016
- Headquarters: San Francisco, California, US
Vir Biotechnology, founded in 2016 and headquartered in San Francisco, California, is a biotechnology company focused on developing treatments for infectious diseases. The company has gained prominence for its work on HIV, influenza, and COVID-19, using a combination of monoclonal antibodies and other innovative technologies. Vir’s collaboration with Gilead Sciences on the development of the monoclonal antibody sotrovimab for COVID-19 is one of its key achievements. The company’s research also extends into other viral diseases, and Vir is committed to addressing some of the most pressing global health challenges through its innovative therapies.
BioMarin Pharmaceuticals: Transforming the Treatment of Rare Genetic Diseases
- Revenue (TTM): $2.01 billion
- Founded: 1997
- Headquarters: California, US
BioMarin Pharmaceuticals, founded in 1997 and headquartered in San Rafael, California, is a leading biotechnology company specializing in treatments for rare genetic diseases. BioMarin’s portfolio includes innovative therapies for conditions such as phenylketonuria (PKU), mucopolysaccharidosis, and hemophilia. The company is known for its development of gene therapies and enzyme replacement therapies, which have provided life-changing treatments for patients with rare diseases. BioMarin’s commitment to improving the lives of individuals with genetic disorders has positioned it as a leader in the rare disease space, making a significant impact on global healthcare.
Flatiron Health: Advancing Cancer Research and Treatment
- Revenue (TTM): $1.2 billion (2022)
- Founded: 2012
- Headquarters: New York, US
Flatiron Health, founded in 2012 and headquartered in New York City, is a health technology company that focuses on leveraging data and technology to improve cancer research and care. The company provides an oncology-specific electronic health record (EHR) system, as well as powerful data analytics tools that allow researchers and healthcare providers to make more informed decisions. Flatiron Health’s innovative platform is used by healthcare professionals and researchers to accelerate cancer research and improve clinical outcomes. In 2018, the company was acquired by Roche, further strengthening its mission to advance personalized cancer treatment and improve patient care.
Sun Pharmaceuticals: A Global Leader in Generic and Specialty Pharmaceuticals
- Revenue (TTM): $5.6 billion (2023)
- Founded: 1983
- Headquarters: Mumbai, India
Sun Pharmaceuticals, founded in 1983 and headquartered in Mumbai, India, is one of the largest pharmaceutical companies in the world. The company specializes in generic drugs, over-the-counter (OTC) products, and specialty pharmaceuticals, with a strong presence in dermatology, oncology, and neurology. Sun Pharmaceuticals has a global footprint, serving markets across North America, Europe, and emerging economies. The company is committed to providing affordable medications while advancing innovative therapies, making it a key player in both the generics market and specialty pharmaceutical treatments.
The Biotech Revolution
These companies represent some of the most prominent players in the biotech industry, driving significant innovations in healthcare, pharmaceuticals, and genetics. Their contributions to the field, from developing groundbreaking treatments to advancing diagnostic technologies, are shaping the future of global healthcare.
The global biotech sector continues to grow exponentially, with companies at the forefront of driving innovations in healthcare and drug development. From pandemic response to groundbreaking genetic therapies, these companies are poised to impact lives for generations. With the industry’s projected revenue surpassing $3 trillion by 2030, biotech firms are securing their place as key players in shaping the future of medicine and human health.
Read more: USA’s Top 10 AI Healthcare Companies Making Waves in 2024
